Finally, to specifically evaluate whether EP2/EP4-deficient antigen-specific CD8+ T cells mount protective anticancer responses, we analysed the growth of MC38-OVA tumours transplanted into WT mice with or without transfer of WT or EP2/EP4-deficient OT-I T cells. The gene discussed is CD8A; the disease is neoplasm.